National STD CurriculumLogo

STD Question Bank

TrichomoniasisQuestion 10/10

A 43-year-old woman with HIV who is taking antiretroviral therapy is seen in clinic for a follow-up visit. Recent laboratory studies showed a CD4 count of 512 cells/mm3 and an undetectable plasma HIV RNA level. At the visit, she is evaluated for vaginal discharge and is diagnosed with trichomoniasis.

Which one of the following is the recommended choice for the treatment of trichomoniasis in this woman with HIV?

In this trial, as shown, higher failure rates occurred with single-dose therapy.
Figure 1. Single Dose or 7-Day Course of Metronidazole Treatment of Trichomonas in Women with HIV
In this trial, as shown, higher failure rates occurred with single-dose therapy.
Source: Kissinger P, Mena L, Levison J, et al. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr. 2010;55:565-71.
Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
March 16th, 2025

Steps to acquire a Certificate for this Lesson:

1

Answer Questions

Answer the board-review style questions
2

Answer Correctly

Score 80% on questions
3

Give Feedback

Complete survey
4

Print Certificate

Document work

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.